Symbol: |
PLA2G6
|
Description: |
phospholipase A2, group VI (cytosolic, calcium-independent) [Source:HGNC Symbol;Acc:9039]
|
Location: |
Chr22:38507502-38588107[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:246
Gene |
Compound |
Gen_sig |
Exp_pattern |
PLA2G6 |
NSC 721877 |
0.003 |
Down |
PLA2G6 |
2-fluorphenylhydrazone alpha-lapachone |
0.001 |
Up |
PLA2G6 |
4-[4-(2-Diethylamino-ethylamino)-naphthalen-1-ylazo]-benzene sulfonamide |
0.016 |
Down |
PLA2G6 |
NSC 722876 |
0.001 |
Down |
PLA2G6 |
Pyridone-OCH3 |
0.001 |
Up |
PLA2G6 |
S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate |
0.002 |
Down |
PLA2G6 |
4,11-dihydroxy-1-[4-(4-hydroxy-1-piperidinyl)butyl]-1H-napht ho[2,3-f]indole-5,10-dione |
0.004 |
Down |
PLA2G6 |
Dasatinib |
0.007 |
Up |
PLA2G6 |
NSC 732719 |
0.001 |
Down |
PLA2G6 |
Everolimus |
0.001 |
Up |
PLA2G6 |
6-(3-Azido-propyl)-2,3-dimethoxthy-5,11-dioxo-5,11-dihydro-6 H-indeno[1,2-c]isoquinoline-9-carbonitrile |
0.005 |
Up |
PLA2G6 |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.025 |
Up |
PLA2G6 |
NSC 736020 |
0.033 |
Up |
PLA2G6 |
NSC 736021 |
0.004 |
Up |
PLA2G6 |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.002 |
Down |
Expression pattern: Sensitivity / Resistance
Total:17 Current:15
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:16
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:38
Total:3 Current:1
[First] [Prev]  Next Last 
|